These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2252808)

  • 1. Phenytoin affects osteocalcin secretion from osteoblastic rat osteosarcoma 17/2.8 cells in culture.
    Vernillo AT; Rifkin BR; Hauschka PV
    Bone; 1990; 11(5):309-12. PubMed ID: 2252808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of phenytoin on collagenase and gelatinase activities in UMR 106-01 rat osteoblastic osteosarcoma cells.
    Vernillo AT; Ramamurthy NS; Lee HM; Rifkin BR
    Matrix; 1990 Mar; 10(1):27-32. PubMed ID: 2161999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of cadmium to rat osteosarcoma cells (ROS 17/2.8): protective effect of 1 alpha,25-dihydroxyvitamin D3.
    Angle CR; Thomas DJ; Swanson SA
    Toxicol Appl Pharmacol; 1990 Mar; 103(1):113-20. PubMed ID: 2315924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and biochemical evidence for the regulation of osteocalcin secretion by potassium channels in human osteoblast-like MG-63 cells.
    Moreau R; Aubin R; Lapointe JY; Lajeunesse D
    J Bone Miner Res; 1997 Dec; 12(12):1984-92. PubMed ID: 9421231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead impairs the production of osteocalcin by rat osteosarcoma (ROS 17/2.8) cells.
    Long GJ; Rosen JF; Pounds JG
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):270-7. PubMed ID: 2256116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
    Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead inhibits the basal and stimulated responses of a rat osteoblast-like cell line ROS 17/2.8 to 1 alpha,25-dihydroxyvitamin D3 and IGF-I.
    Angle CR; Thomas DJ; Swanson SA
    Toxicol Appl Pharmacol; 1990 Apr; 103(2):281-7. PubMed ID: 2330589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
    Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
    J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum stimulates the proliferation and differentiation of osteoblasts in vitro by a mechanism that is different from fluoride.
    Lau KH; Yoo A; Wang SP
    Mol Cell Biochem; 1991 Jul; 105(2):93-105. PubMed ID: 1922012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the involvement of bone morphogenetic protein-2 in phenytoin-stimulated osteocalcin secretion in human bone cells.
    Koyama H; Nakade O; Saitoh T; Takuma T; Kaku T
    Arch Oral Biol; 2000 Aug; 45(8):647-55. PubMed ID: 10869476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C does not mediate the inhibitory action of lead on vitamin D3-dependent production of osteocalcin in osteoblastic bone cells.
    Guity P; McCabe MJ; Pitts DK; Santini RP; Pounds JG
    Toxicol Appl Pharmacol; 2002 Jan; 178(2):109-16. PubMed ID: 11814331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism.
    Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood B
    Endocrinology; 1991 May; 128(5):2577-82. PubMed ID: 2019266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation by 1,25-dihydroxy-vitamin D3.
    Nambi P; Wu HL; Lipshutz D; Prabhakar U
    Mol Pharmacol; 1995 Feb; 47(2):266-71. PubMed ID: 7870034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts.
    Koshihara Y; Hoshi K; Ishibashi H; Shiraki M
    Calcif Tissue Int; 1996 Dec; 59(6):466-73. PubMed ID: 8939773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective effect of thiazides on the human osteoblast-like cell line MG-63.
    Aubin R; Ménard P; Lajeunesse D
    Kidney Int; 1996 Nov; 50(5):1476-82. PubMed ID: 8914012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
    Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
    J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of desferrioxamine and deferiprone on osteocalcin secretion in osteoblast-type cells].
    González Suárez I; Fernández Martín JL; Naves Díaz M; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():27-31. PubMed ID: 12778850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption.
    van den Bemd GJ; Pols HA; Birkenhäger JC; Kleinekoort WM; van Leeuwen JP
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):337-46. PubMed ID: 8541230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma inhibits 1,25-dihydroxyvitamin D3-stimulated synthesis of bone GLA protein in rat osteosarcoma cells by a pretranslational mechanism.
    Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood BD
    Endocrinology; 1990 Aug; 127(2):588-94. PubMed ID: 2115429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological activities of 1alpha,25-dihydroxyvitamin D3 and its synthetic analog 1alpha,25-dihydroxy-16-ene-vitamin D3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-beta estradiol and dependent on stage of differentiation.
    Rao LG; Liu LJ; Rawlins MR; McBroom RJ; Murray TM; Reddy GS; Uskokovic MR; Rao DS; Sutherland MK
    Biol Pharm Bull; 2001 Mar; 24(3):242-8. PubMed ID: 11256478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.